CAMNUVIQ Trademark

Trademark Overview

On Wednesday, September 3, 2025, a trademark application was filed for CAMNUVIQ with the United States Patent and Trademark Office. The USPTO has given the CAMNUVIQ trademark a serial number of 99371421. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 3, 2025. This trademark is owned by Glaxo Group Limited. The CAMNUVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
camnuviq

General Information

Serial Number99371421
Word MarkCAMNUVIQ
Filing DateWednesday, September 3, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, September 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Trademark Events

Event DateEvent Description
Wednesday, September 3, 2025NEW APPLICATION ENTERED
Wednesday, September 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 3, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

camnuviq pharmaceutical preparations diseases infectious treatment dermatological psychiatric gastrointestinal neurological respiratory